Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Annals of Gastroenterology
|
April 28, 2022
Outcomes in patients with inflammatory bowel disease and acute gastrointestinal symptoms who test indeterminate for <i>Clostridioides difficile</i>
Lauren K Johnson, Silvia Munoz-Price, Poonam Beniwal Patel, et al.
Frontiers in Neuroscience
|
February 15, 2024
Structural brain morphometry differences and similarities between young patients with Crohn's disease in remission and healthy young and old controls
Benjamin Yeske, Jiancheng Hou, Daniel Y Chu, et al.
Gastroenterology Research
|
May 8, 2024
Predictive Factors of Non-Inflammatory Small Bowel Obstruction After Bowel Resection in Crohn's Patients
Mir Zulqarnain, Fouad Jaber, Vinay Jahagirdar, et al.
The American Journal of Gastroenterology
|
February 13, 2026
The bidirectional relationship between cognitive function and active inflammatory bowel disease
Bharati Kochar, Adam S Faye, Elizabeth Araka, et al.
Digestive Diseases and Sciences
|
October 24, 2019
Correction to: Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases
Andres J Yarur, Alexandra Bruss, Snehal Naik, et al.
Digestive Diseases and Sciences
|
March 6, 2019
Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases
Andres J Yarur, Alexandra Bruss, Snehal Naik, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 24, 2022
Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab
Andres J Yarur, Dermot McGovern, Maria T Abreu, et al.
Gastroenterology
|
July 27, 2023
Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study
Andres J Yarur, Alexandra Bruss, Andrea Moosreiner, et al.
The American Journal of Gastroenterology
|
November 17, 2023
Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the Pouch
Maia Kayal, Parakkal Deepak, Poonam Beniwal-Patel, et al.
The American Journal of Gastroenterology
|
May 19, 2023
Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission
Andres J Yarur, Maria T Abreu, Parakkal Deepak, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Annals of Gastroenterology
|
April 28, 2022
Outcomes in patients with inflammatory bowel disease and acute gastrointestinal symptoms who test indeterminate for <i>Clostridioides difficile</i>
Lauren K Johnson, Silvia Munoz-Price, Poonam Beniwal Patel, et al.
Frontiers in Neuroscience
|
February 15, 2024
Structural brain morphometry differences and similarities between young patients with Crohn's disease in remission and healthy young and old controls
Benjamin Yeske, Jiancheng Hou, Daniel Y Chu, et al.
Gastroenterology Research
|
May 8, 2024
Predictive Factors of Non-Inflammatory Small Bowel Obstruction After Bowel Resection in Crohn's Patients
Mir Zulqarnain, Fouad Jaber, Vinay Jahagirdar, et al.
The American Journal of Gastroenterology
|
February 13, 2026
The bidirectional relationship between cognitive function and active inflammatory bowel disease
Bharati Kochar, Adam S Faye, Elizabeth Araka, et al.
Digestive Diseases and Sciences
|
October 24, 2019
Correction to: Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases
Andres J Yarur, Alexandra Bruss, Snehal Naik, et al.
Digestive Diseases and Sciences
|
March 6, 2019
Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases
Andres J Yarur, Alexandra Bruss, Snehal Naik, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 24, 2022
Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab
Andres J Yarur, Dermot McGovern, Maria T Abreu, et al.
Gastroenterology
|
July 27, 2023
Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study
Andres J Yarur, Alexandra Bruss, Andrea Moosreiner, et al.
The American Journal of Gastroenterology
|
November 17, 2023
Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the Pouch
Maia Kayal, Parakkal Deepak, Poonam Beniwal-Patel, et al.
The American Journal of Gastroenterology
|
May 19, 2023
Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission
Andres J Yarur, Maria T Abreu, Parakkal Deepak, et al.
Page
of 3